Discover 227 paid clinical trials in Peoria, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 227
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Peoria IL, Decatur IL, Urbana IL,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase 3, Recruiting
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
for
Normal and Diseased Tissue and Body Fluids Samples
Location: Peoria IL, Springfield MO, Memphis TN, Huntsville AL,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT01354002
Recruiting
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
Location: Peoria IL, Springfield IL, Oak Lawn IL, Iowa City IA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Peoria IL, Maywood IL, Iowa City IA, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Peoria IL, Springfield IL, Oak Lawn IL, Iowa City IA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Peoria IL, Iowa City IA, Chicago IL, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
Stress Hydrocortisone In Pediatric Septic Shock
for
Septic Shock
Location: Peoria IL, Chicago IL, Madison WI, Louisville KY,
Sponsor: Jerry Zimmerman
Sex: All
Age: 0 - 17
Code: NCT03401398
Phase 3, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Peoria IL, Springfield IL, Iowa City IA, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase 3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Peoria IL, Winfield IL, Oak Lawn IL, Maywood IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Peoria IL, Springfield IL, Winfield IL, Oak Lawn IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Location: Peoria IL, Springfield IL, Oak Lawn IL, Maywood IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase 2, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Peoria IL, Springfield IL, Iowa City IA, Chicago IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase 3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study